Cargando…
Potential pitfalls in diagnosis of immunotherapy-induced hypothalamic–pituitary–adrenal axis suppression
Autores principales: | Mc Donald, Darran, Crowley, Rachel Katherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259334/ https://www.ncbi.nlm.nih.gov/pubmed/37435461 http://dx.doi.org/10.1530/EO-22-0069 |
Ejemplares similares
-
Potential pitfalls in diagnosis of immunotherapy-induced hypothalamic–pituitary–adrenal axis abnormalities: a clinical case
por: Bi, Yixi, et al.
Publicado: (2022) -
Methamphetamine and the hypothalamic-pituitary-adrenal axis
por: Zuloaga, Damian G., et al.
Publicado: (2015) -
Hyposecretion of the Adrenal Androgen Dehydroepiandrosterone Sulfate (DHEA-S) in the Majority of the Alopecia Areata Patients: Is it a Primitive and Pathogenic Perturbation of Hypothalamic-Pituitary-Adrenal Axis?
por: d’Ovidio, Roberto, et al.
Publicado: (2011) -
The Role of the Endocannabinoids in Suppression of the Hypothalamic-pituitary-adrenal Axis Activity by Doxepin
por: Hassanzadeh, Parichehr, et al.
Publicado: (2011) -
Systemic absorption of intranasal corticosteroids may occur and can potentially affect the hypothalamic–pituitary–adrenal axis
por: Kline, Gregory A., et al.
Publicado: (2021)